Introduction {#Sec1}
============

Carbon tetrachloride (CCl~4~) is a common environmental pollutant and liver carcinogen. Due to its detoxifying function in protecting the body, the liver is a target for CCl~4~ toxicity \[[@CR1]\]. Antioxidants and anti-inflammatory agents play a critical role in liver protection by scavenging superoxide anion radicals (SAR) and neutralizing lipid peroxides (LPO). They also suppress the inflammatory response \[[@CR2]--[@CR4]\]. Therefore, there is need for a natural product that protects the liver, but is also cost-effective and safe, without long-term side effects. This study evaluated the liver protective potential of the fruit juice of *Morinda citrifolia* (Noni), from Tahiti, a strong antioxidant and anti-inflammatory nutritional supplement.

We have previously reported that Noni juice is an effective antioxidant, demonstrating a dose-dependent effect against SAR and LPO *in vitro* \[[@CR5]\]. Based on the data from our laboratory and others, we suggested that Noni juice may be effective in protecting the liver against acute CCl~4~ toxicity. To test our hypothesis, a classic CCl~4~-induced liver injury model was chosen to study the liver protective effect in female SD rats. Morphological change is the most direct sign of liver injury. Histopathological changes were evaluated for morphological evidence of the liver protective properties of Noni juice. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) assays that measure liver function were performed on the Noni group (Noni + CCl~4~) and compared to those of the positive control group (placebo + CCl~4~).

Materials and Methods {#Sec2}
=====================

Materials {#Sec3}
---------

Carbon tetrachloride was purchased from Sigma Chemical Co., St. Louis, MO, USA. Noni juice was made by Morinda Holdings Inc. (Provo, UT, USA) from Noni fruit originating in Tahiti. The placebo was prepared using the same procedures and ingredients for making Tahitian Noni® Juice (TNJ), but without the Noni component.

Animals {#Sec4}
-------

Six-week-old female SD rats were purchased from Charles River Inc. (Wilmington, MA, USA). The animals were housed in a room maintained at 25 °C with a 12 h photoperiod. They were fed a laboratory chow diet and water *ad libitum*. The experimental design for these tests was approved by the Institutional Ethics Review Committee for animal experiments at the National Cancer Center.

Experiment 1 {#Sec5}
------------

### Animal Treatment {#Sec6}

Sixteen female SD rats were divided into two groups of eight each. Both groups were provided drinking water for 7 days. Twenty percent placebo was added to the drinking water in one group and 20% Noni juice in the other. On day 8, four animals from each group were fed 0.5 mL/kg CCl~4~ in corn oil. All animals were sacrificed at 6 h post-CCl~4~ administration. The liver was removed and fixed in 10% neutral formalin for histological examination. Blood was collected from each animal for serum AST and ALT activity to examine liver function.

### LM Examination {#Sec7}

Liver samples were preserved in 10% neutral buffered formalin and dehydrated in a graded alcohol series. Following xylene treatment, the specimens were embedded in paraffin blocks and cut into 5 μm thick sections. Consecutive sections were stained with hematoxylin and eosin (H & E) and examined under an Olympus BH2 light microscope. The number of foci/mm^2^ was counted to assess the degree of necrosis \[[@CR6]\]. Digital images were recorded with the Pixera Visual Communication Suite.

### ALT and AST Assay {#Sec8}

Serum was separated from clotted blood by centrifugation at 1,600 rpm for 10 min at 4 °C. Serum ALT and AST activities were measured using an automatic biochemical analyzer calibrated with quality control standards (E.I. du Pont de Nemours) in a clinical laboratory (Family Medicine Laboratory, UIC College of Medicine at Rockford).

Experiment 2 {#Sec9}
------------

### Animal Treatments {#Sec10}

Thirty-six female SD rats were divided into two groups of 18 each. While dose range-finding experiments revealed that maximum protection occurred with 20% Noni juice in drinking water, optimum protection (per amount ingested) occurred with 10%. Therefore, each group was supplied 10% placebo or 10% Noni juice in drinking water for 12 days. On day 13, 15 animals from each group were fed 0.25 mL/kg CCl~4~ in corn oil. Three animals from each group were sacrificed at 1, 3, 6, 16, and 24 h post-CCl~4~ administration. The remaining three animals in each group were fed 1 mL/kg corn oil and sacrificed 1 h later, to serve as vehicle placebo and Noni controls. Multiple liver-tissue samples were removed from each rat to be fixed for LM examination.

### LM Examination {#Sec11}

Liver samples for experiment 2 were prepared and observed for light microscopy as described in experiment 1.

### Statistical Analysis {#Sec12}

Statistical analysis was done by a Student two-tail *T* test \[[@CR7]\]. Differences were considered as significant at *P* \< 0.05 and highly significant at *P* \< 0.01. Results were expressed as mean ± SD.

Results and Discussion {#Sec13}
======================

In experiment 1, the liver lobular structure among rats treated 6 h earlier with 20% placebo or 20% Noni juice did not reveal any noticeable histological changes (Fig. [1](#Fig1){ref-type="fig"}a,b), which indicates that high-dose pretreatment with Noni juice or placebo does not produce hepatotoxicity. Hepatic sections, from rats pretreated with 20% placebo followed by CCl~4~ treatment, showed typical CCl~4~-induced liver injury (Fig. [1](#Fig1){ref-type="fig"}c). Sections revealed extremely vacuolized hepatocytes (balloon liver cells and apoptotic necrotic cells) adjacent to the central vein (arrows and arrowhead, Fig. [1](#Fig1){ref-type="fig"}c), indicating acute CCl~4~-induced hepatotoxicity. Hepatocytes were significantly protected from CCl~4~-induced toxicity by 20% Noni juice pretreatment (Fig. [1](#Fig1){ref-type="fig"}d), and demonstrated a normal appearance, except for slight steatosis (fatty deposition) in hepatocytes pericentral to the vein. In the CCl~4~ + 20% placebo group, 23.8% of cross-sectional areas contained swollen balloon cells, whereas in the CCl~4~ + 20% Noni group, only 1.9% contained vacuolized cells (*P* \< 0.001). Furthermore, the apoptotic cells were dramatically decreased by 50% in the Noni pretreated group when compared with the CCl~4~ + placebo group (*P* \< 0.001). Fig. 1H & E liver sections (250X), from female SD rats showing protective effect of 20% Noni pretreatment **d** on acute hepatotoxicity at 6 h post-CCl~4~ exposure (0.5 mL/kg CCl~4~ in corn oil). The rats in **a** (control) and **b** (noni treated) received no CCl~4~ exposure, and show no signs of liver-cell damage. With CCl~4~ exposure, there are significant hepatotoxicity effects: balloon liver cells and apoptotic necrotic cells adjacent to the central vein (*arrow* and *arrowhead* (**c)**). **d** In contrast, with Noni pretreatment + CCl~4~ exposure, shows no signs of hepatotoxicity. **b** and **d** (noni treated) show cell patterns that are more ordered, and show no signs of hepatotoxicity

In experiment 2, 10% Noni + CCl~4~ pretreatment resulted in a delayed appearance of damaged hepatocytes with a significantly decreased number of necrotic foci (80%) and apoptosis (50%), compared to the placebo group at 3, 6, and 16 h (arrows and arrowhead, Fig. [2](#Fig2){ref-type="fig"}b,d,f). These results indicate that Noni juice protects the liver from acute CCl~4~ exposure. Cellular damage consisted of vacuolated hepatocytes and inflammatory cells surrounding the central vein in the placebo + CCl~4~ group (Fig. [2](#Fig2){ref-type="fig"}b,d,f). Conversely, liver lobules in the Noni juice + CCl~4~ group maintained a normal appearance in each of the post-treatment time intervals (Fig. [2](#Fig2){ref-type="fig"}a,c,e). Fig. 2Rat liver sections (100×), showing representative sequential hepatopathology at 3, 6, or 16 h following pretreatments with 10% Noni juice, or placebo, plus 0.25 mL/kg CCl~4~. Panels: **a** 3 h post-CCl~4~ + Noni juice (normal hepatic structure); **b** 3 h post-CCl~4~ + placebo, (first stages of hepatocyte swelling pericentral to vein; *arrow* denotes swollen hepatocytes); **c** 6 h post-CCl~4~ + Noni (normal hepatic structure); **d** 6 h post-CCl~4~ + placebo, (increased number and degree of swollen hepatocytes); **e** 16 h post-CCl~4~ + Noni (balloon cells adjacent to pericentral vein, and delayed response of hepatotoxicity); and **f** 16 h post-CCl~4~ + placebo (increase in number of damaged foci, and an extension of damaged area midzonal to vein; *arrow* indicate swollen hepatocytes, *arrowhead* denotes inflammatory foci)

Comparative histopathological changes of the Noni juice and placebo-treated groups, at 3 h post-0.25 mL/kg CCl~4~ treatment, are shown in Fig. [3](#Fig3){ref-type="fig"}. The effects of 10% Noni juice on reducing inflammation surrounding the central vein area (Fig. [3](#Fig3){ref-type="fig"}a), and the absence of swollen hepatocytes are clearly shown in the H & E sections. In Fig. [3](#Fig3){ref-type="fig"}b, a similar liver section from the CCl~4~ + 10% placebo treatment reveals swollen hepatocytes and a massive influx of inflammatory cells (arrow and arrowheads, Fig. [3](#Fig3){ref-type="fig"}a,b). Fig. 3H & E cross sections (150×), of pericentral vein areas showing inhibitory effect of 10% Noni juice on inflammation at 3 h post-0.25 mL/kg CCl~4~-induced acute hepatotoxicity (**a**), versus placebo + CCl~4~ (**b**). *Arrows* denote increased foci of inflammatory cells, *arrowheads* indicate swollen hepatocytes

Noni Juice Suppresses ALT and AST Activities {#Sec14}
--------------------------------------------

Serum ALT and AST activities were determined for enzymatic evidence of liver injury (Table [1](#Tab1){ref-type="table"}). The protective effect of Noni juice against CCl~4~-induced hepatotoxicity was demonstrated by a significant 50% suppression (*P* \< 0.05) of ALT activity compared to the placebo. AST activity in the Noni juice pretreated group was significantly suppressed by 68% (*P* \< 0.01), compared to the placebo. As noted in the table, the 20% placebo or 20% Noni juice in drinking water for 7 days did not influence liver function compared with the control. In contrast, the 20% placebo + CCl~4~ treatment produced acute liver damage as measured by elevated serum ALT and AST activities. Table 1Effect of Noni juice on acute CC1~4~-induced hepatitis in SD ratsTreatmentALT (IU/L)AST (IU/L)Control67 ± 31^\*\*^222 ± 121^\*\*^Placebo (20%)67 ± 26^\*\*^222 ± 99^\*\*^Noni juice (20%)65 ± 59^\*\*^184 ± 31^\*\*^Placebo (20%) + CCl~4~ 0.5 mL/kg^a^136 ± 411135 ± 466Noni juice (20%) + CCl~4~ 0.5 mL/kg68 ± 12^\*\*^358 ± 69^\*a^Data from each group were compared to that of the positive control group (20% placebo + 0.5 mL/kg CC1~4~). Data are expressed as means ± SD (*n* = 4). Student two-tail *T* test^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01

The present study supports the protective effects of Noni juice on acute CCl~4~-induced hepatotoxicity. Necrosis of hepatocytes was minimized in livers of animals pretreated with Noni juice in both experiments. Noni juice prevented free-radical-induced oxidative-pathological events.

Damaged hepatocytes release ALT and AST enzymes following acute exogenous toxin exposure. Therefore these elevated serum enzyme levels are good chemical indicators of liver damage. Noni juice is able to normalize liver function after acute exposure to CCl~4~. Serum ALT and AST activity, a measure of defense enzyme levels, was significantly suppressed after CCl~4~ exposure in the Noni juice pretreated animals, compared with the elevated enzyme levels in the placebo pretreated animals. Therefore, pretreatment with Noni juice indeed protected hepatocytes from acute CCl~4~ exposure.

A few reports have suggested the involvement of Noni juice in the development of chemically induced hepatitis in a limited number of cases in Europe. However, no causal role has been established in any of these instances. Further, an official European investigation of these cases determined that no relationship between Noni juice and hepatitis was evident and that consumption of Noni juice is unlikely to induce adverse human liver effects \[[@CR8]\]. Animal and human studies have revealed that Noni juice is not hepatotoxic, even at very high doses \[[@CR9], [@CR10]\].

Conclusions {#Sec15}
===========

Our investigation suggests that Noni juice exerts effective protection against acute extrinsic chemical induced hepatic injury by inhibiting inflammatory response and suppressing elevated liver enzyme activities; thus preventing consequent cell membrane damage. Histopathological observations revealed morphological evidence, and bioassays revealed functional evidence, that Noni confers resistance to acute CCl~4~-induced hepatotoxicity. High dosages of Noni and placebo pretreatments did not induce liver damage. Noni may thus be an efficacious natural hepatoprotective nutritional supplement against chemically induced hepatotoxicity. Future studies should focus on how Noni juice influences the inflammatory and cytotoxic cytokines involved in liver injury.
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